- HEALTH INFORMATION
- GET SUPPORT
- NEWS & VIEWS
- GET INVOLVED
- CARE PROVIDERS
Periodically, the Preeclampsia Foundation makes arrangements with investigators to make enrollment information available about their studies. The following preeclampsia research trials have been approved by Institutional Review Boards. If you are interested in participating in one of the following studies, please contact the primary study investigator directly to inquire about enrollment. Listing of these studies on this site does not constitute an endorsement or recommendation by the Preeclampsia Foundation.
Preeclampsia survivors and those at risk for these pregnancy complications should seek to understand the benefits, alternatives and risks of participating in any research study, including those intended to study prevention or therapeutic interventions. Please know that the choice to participate in any research study is up to you.
We are working with external investigators to analyze data from The Preeclampsia Registry to answer a variety of research questions.
Have you or any of your family members EVER had preeclampsia or high blood pressure in pregnancy?
Please consider enrolling in The Preeclampsia Registry at www.PreeclampsiaRegistry.org. Preeclampsia and related hypertensive disorders of pregnancy are life-threatening to the mother and her unborn baby. Your story, medical and pregnancy history, and ongoing health reporting will help scientists unravel all the pieces of this puzzle.
Our goal is to have well over 10,000 participants including women directly affected, their sisters, and even friends who were not affected (to serve as “controls”). To learn more or enroll, go to www.PreeclampsiaRegistry.org. If you have questions, please email Registry@Preeclampsia.org.
Research Study: PRESERVE-1
Goal: For women diagnosed with preeclampsia between 23 and 30 weeks:
Who can participate?
The PRESERVE-1 study will include 120 women at over 20 locations in North America.
Little Rock, AR
New Haven, CT
New Orleans, LA
St. Louis, MO
New York, NY
Oklahoma City, OK
Salt Lake City, UT
PRESERVE-1 is a Phase 3 clinical study for women who are diagnosed with preeclampsia between 23-30 weeks of their pregnancy. This study will assess if antithrombin (Recombinant), a man-made version of a naturally occurring blood protein, can increase the time that your baby stays in the womb, decrease the problems that you may experience or improve the health and well-being of your baby.
What to Expect:
Participation in this study will involve gathering your medical history, physical exams, blood and urine collection, taking the study medication, and monitoring for side effects under observation by a physician. Some participants will receive the medication and some participants will receive a placebo, which is a saline solution without active ingredients. Your baby will also be followed after delivery.
Research Study: Heart Health 4 Moms (HH4M)
This online research study, Heart Health 4 Moms (HH4M), focuses on healthy behaviors in new mothers with recent preeclampsia to improve their long-term health. You must live in a U.S. state or territory and have access to an internet-enabled smartphone or tablet. Up to $250 stipend will be provided. This research is being conducted by Brigham & Women’s Hospital in Boston and the Preeclampsia Foundation.
Learn more at www.HH4M.org.
In addition, ClinicalTrials.gov is a registry of most federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details.
Investigators interested in our Study Participant Recruitment Services should contact the Preeclampsia Foundation at email@example.com.